Company news
United Therapeutics Corporation news in 2020
United Therapeutics Corporation's news releases, calls and decks from 2020, newest first.
United Therapeutics Announces Agreement To Acquire Priority Review Voucher
December 27, 2020
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
December 8, 2020
United Therapeutics Releases Its First Corporate Responsibility Report
November 23, 2020
United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference
November 9, 2020
United Therapeutics Corporation To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference
November 1, 2020
United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
October 27, 2020
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
October 21, 2020
United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020
October 20, 2020
United Therapeutics to Present New Tyvaso® Clinical and Treprostinil Real-World Data at CHEST Annual Meeting 2020
October 14, 2020
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
September 20, 2020
United Therapeutics Corporation to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 15, 2020
United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors
September 10, 2020
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease
August 16, 2020
United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual Conference
August 4, 2020
United Therapeutics Corporation Reports Second Quarter 2020 Financial Results
July 28, 2020
United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia
July 22, 2020
United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020
July 21, 2020
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
June 16, 2020
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents
June 4, 2020
United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference
May 25, 2020
United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020
May 5, 2020
United Therapeutics Corporation Reports First Quarter 2020 Financial Results
April 28, 2020
United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension
April 22, 2020
United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020
April 21, 2020
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results
February 25, 2020
United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference
February 24, 2020
United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints
February 23, 2020
United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®
February 23, 2020
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020
February 18, 2020
United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen
February 3, 2020
United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint
February 2, 2020